Join SPINS Market Insights Director Scott Dicker, food and dietary supplement FDA regulatory attorney Martin Hahn, The Clean Label Project founder Jackie Bowen, and Radicle Science co-founders Dr. Jeff Chen and Pelin Thorogood as we explore the new FTC guidelines and what they could mean for the future of the supplement industry.
KEY LEARNING OBJECTIVES INCLUDE:
- Understand the role of FTC vs. FDA related to claims enforcement and the possible consequences of making impermissible claims.
- Learn the key changes and clarifications in the Health Products Compliance Guide vs. the FTC’s 1998 publication.
- Get valuable tips on how to evaluate your current claims and their level of risk.
- Learn what type of clinical trials may be required for permissible claims, the investment needed, and the possible ROI from claims.
- Why these updated guidelines might be good for the industry and your business.
Pelin Thorogood
Radicle Science
M. Eng, MBA - Co-founder, Executive Chairwoman
Jeff Chen
Radicle Science
MD, MBA - Co-founder, Chief Executive Officer
Jaclyn Bowen
Clean Label Project
MPH, MS - Executive Director
Martin Hahn
Hogan Lovells
JD - Partner
Scott Dicker
SPINS
Senior Market Insights Analyst